Table 5.
Clinical complications
|
Group A |
Group B |
p-value |
|
|---|---|---|---|
|
After 1 week | |||
|
Swelling |
5 (33.3%) |
10 (66.7%) |
0.1 |
|
Membrane exposure |
3 (23.1%) |
10 (76.9%) |
0.02* |
|
Infection |
4 (44.4%) |
5 (55.6%) |
0.9 |
|
After 1 month | |||
|
Swelling |
– |
– |
– |
|
Membrane exposure |
1 (11.1%) |
8 (88.9%) |
0.01* |
|
Infection |
1 (20.0%) |
4 (80.0%) |
0.2 |
|
After 3 months | |||
|
Swelling |
– |
– |
– |
|
Membrane exposure |
1 (11.2%) |
8 (88.9%) |
0.01* |
|
Infection |
0 |
3 (100.0%) |
0.09 |
|
Failure |
0 |
3 (100.0%) |
0.09 |